Correlation Between Indaptus Therapeutics and Forte Biosciences
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Forte Biosciences, you can compare the effects of market volatilities on Indaptus Therapeutics and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Forte Biosciences.
Diversification Opportunities for Indaptus Therapeutics and Forte Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Indaptus and Forte is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Forte Biosciences go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Forte Biosciences
Given the investment horizon of 90 days Indaptus Therapeutics is expected to under-perform the Forte Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Indaptus Therapeutics is 5.63 times less risky than Forte Biosciences. The stock trades about -0.36 of its potential returns per unit of risk. The Forte Biosciences is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 462.00 in Forte Biosciences on August 28, 2024 and sell it today you would earn a total of 1,146 from holding Forte Biosciences or generate 248.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Forte Biosciences
Performance |
| Timeline |
| Indaptus Therapeutics |
| Forte Biosciences |
Indaptus Therapeutics and Forte Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Forte Biosciences
The main advantage of trading using opposite Indaptus Therapeutics and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Forte Biosciences vs. Eliem Therapeutics | Forte Biosciences vs. HCW Biologics | Forte Biosciences vs. Scpharmaceuticals | Forte Biosciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |